Medical Blog About Treatment Abroad

According to MDPI clinical data, melanoma accounts for 1.7% of global cancer diagnoses and is the fifth most common cancer in the US. Melanoma incidence is rising in developed, predominantly fair-skinned countries, growing over 320% in the US since 1975. That is why it is very important to look for new effective treatments...

Liver cancer typically strikes between the ages of 50 and 65, ranking as the 5th most common cancer in men and 9th in women. The sobering reality is that three-quarters of cases go undetected until the disease has already spread – a stage 4 diagnosis that traditionally meant a prognosis measured in months, not years.

The second most common cancer diagnosis in men and the fifth cause of cancer deaths all over the world is prostate cancer. GLOBOCAN 2018 reports that the number of new cases was 1,276,106 cases worldwide, with the main increase in developed countries. The mortality and the incidence are closely associated with age, and the rates...

Neuroendocrine tumors have shown a significant increase in prevalence over the past two decades. Between 2000 and 2018, the age-standardized incidence increased from 4.9 to 8.2 cases per 100,000 population, with the most pronounced increase being among grade 1 tumors, early stages, and appendix neoplasms.

Benign prostatic hyperplasia (BPH) is one of the most common urological conditions in men, especially those aged 50 and older. The number of cases of BPH is rapidly increasing worldwide. According to the data published in The Lancet, the distribution of the disease according to age is as follows: 8% in their 40s, 50%...

Cervical cancer remains one of the most common gynecological malignancies worldwide, with significant disparities in incidence and survival depending on geography and access to care. According to the World Health Organization, over 600,000 women are diagnosed with cervical cancer each year globally, and...

A cancer diagnosis changes everything. Yet colon cancer – one of the most common malignancies worldwide – has never been more treatable, more understood, or more responsive to innovation than it is today. After treatment for colon cancer stage 1, patients achieve five-year survival rates of 90%, while even advanced cases...

Germany is one of the most preferred destinations for stem cell therapy thanks to its strong scientific background, reliable healthcare system, and many clinics where this kind of therapy is carried out. Because of that, the country has become a place of choice for international patients looking for new medical solutions...